BACK TO TOP
KSE100
151,707.51
-1200.45
(-0.79%)
KSE100PR
46,800.23
-375.02
(-0.79%)
ALLSHR
90,950.94
-834.89
(-0.91%)
KSE30
45,918.56
-386.30
(-0.83%)
KMI30
220,125.22
-1889.21
(-0.85%)
BKTI
41,297.63
-248.70
(-0.60%)
OGTI
31,189.41
-809.48
(-2.53%)
KMIALLSHR
59,363.51
-613.27
(-1.02%)
PSXDIV20
69,528.69
-197.44
(-0.28%)
UPP9
54,232.58
-87.86
(-0.16%)
NITPGI
40,519.93
-262.99
(-0.64%)
NBPPGI
43,892.90
-466.96
(-1.05%)
MZNPI
27,126.47
-316.62
(-1.15%)
JSMFI
38,423.14
-426.58
(-1.10%)
ACI
19,383.19
-284.46
(-1.45%)
JSGBKTI
62,029.31
-329.02
(-0.53%)
HBLTTI
18,136.15
26-03-2026
-1.17
(-0.01%)
MII30
19,992.86
-155.04
(-0.77%)
Citi Pharma Ltd.
PHARMACEUTICALS
Rs.73.41
0.53
(0.73%)
1D
1M
6M
YTD
1Y
3Y
5Y
^ As of Fri, Mar 27, 2026 4:49 PM
REG
DFC
CSF
ODL
Open
73.97
High
73.97
Low
72.00
Volume
597,427
CIRCUIT BREAKER
65.59 — 80.17
DAY RANGE
72.00 — 73.97
52-WEEK RANGE ^
60.50 — 105.31
Ask Price
0.00
Ask Volume
0
Bid Price
0.00
Bid Volume
0
LDCP
72.88
VAR
15.00
HAIRCUT
22.50
P/E Ratio (TTM) **
16.10
1-Year Change * ^
-15.69%
YTD Change * ^
-13.23%
Last update: Fri, Mar 27, 2026 4:36 PM
Open
73.00
High
73.80
Low
70.01
Close
73.32
Change
0.45%
LDCP
72.99
Volume
1,436,500
Total Trades
364
CIRCUIT BREAKER
65.69 — 80.29
DAY RANGE
70.01 — 73.80
Ask Price
0.00
Ask Volume
0
Bid Price
0.00
Bid Volume
0
Last update: Fri, Mar 27, 2026 4:35 PM
Open
73.55
High
74.10
Low
71.50
Close
73.72
Change
0.29%
LDCP
73.51
Volume
1,128,500
Total Trades
436
CIRCUIT BREAKER
66.16 — 80.86
DAY RANGE
71.50 — 74.10
Ask Price
0.00
Ask Volume
0
Bid Price
0.00
Bid Volume
0
Last update: Sun, Feb 1, 2026 3:49 AM
Open
0.00
High
0.00
Low
0.00
Close
0.00
Change
0.00%
LDCP
73.73
Volume
0
Total Trades
0
CIRCUIT BREAKER
66.36 — 81.10
DAY RANGE
0.00 — 0.00
Ask Price
0.00
Ask Volume
0
Bid Price
0.00
Bid Volume
0
Last update: Sun, Dec 28, 2025 3:06 AM
Open
0.00
High
0.00
Low
0.00
Close
0.00
Change
0.00%
LDCP
72.91
Volume
0
Total Trades
0
CIRCUIT BREAKER
65.62 — 80.20
DAY RANGE
0.00 — 0.00
Ask Price
0.00
Ask Volume
0
Bid Price
0.00
Bid Volume
0
Last update: Sun, Mar 1, 2026 2:45 AM
Open
0.00
High
0.00
Low
0.00
Close
0.00
Change
0.00%
LDCP
74.76
Volume
0
Total Trades
0
CIRCUIT BREAKER
67.28 — 82.24
DAY RANGE
0.00 — 0.00
Ask Price
0.00
Ask Volume
0
Bid Price
0.00
Bid Volume
0

No record found

Market data powered by capitalstake.com. Provided by PSX. ** Based on unconsolidated financials
  * Returns not adjusted for payouts
  ^The historical stock prices have been adjusted to reflect stock splits to ensure comparability over time.

Company Profile

BUSINESS DESCRIPTION

Citi Pharma Limited incorporated as a private limited company in Pakistan under the repealed Companies Ordinance, 1984 on October 08, 2012. The principal activity of the company is manufacturing and sale of pharmaceuticals, medical chemicals and botanical products.

KEY PEOPLE
Rizwan AhmadCEO
Nadeem AmjadChairperson
Muhammad Rasheed AlamCompany Secretary
ADDRESS

3-KM, Head Balloki Road, Bhai Pheru, Distt Kasur

WEBSITE

www.citipharma.com.pk

REGISTRAR

F.D Registrar Services (Pvt.) Ltd.

AUDITOR

Aslam Malik & Co. Chartered Accountants

Fiscal Year End

June

Equity Profile

Market Cap (000's)
16,771,336.69
Shares
228,461,200
Free Float
114,230,600
Free Float
50.00%

Announcements

Financial Results
Board Meetings
Others
DateTitleDocument
Feb 18, 2026Transmission of Quarterly Financial Statements for the Period Ended 2025-12-31 View   PDF
Feb 13, 2026Financial Results for the Quarter Ended December 31, 2025 View   PDF
Oct 30, 2025TRANSMISSION OF QUARTERLY REPORT FOR THE PERIOD ENDED View   PDF
Oct 29, 2025Financial Results for the Quarter Ended View   PDF
Oct 7, 2025Transmission of Annual Report for the Year Ended View   PDF
DateTitleDocument
Feb 3, 2026Board meeting View   
Feb 3, 2026Board Meeting
REVOKED
View   
Nov 13, 2025Certified True Copy of the Resolutions Passed in the Annual General Meeting View   PDF
Oct 29, 2025Board Meeting Other Than Financial Results (Post Election BOD Meeting) View   
Oct 24, 2025Board Meeting View   
DateTitleDocument
Mar 17, 2026Appointment of Company Secretary View   
Mar 17, 2026Appointment of Chief Financial Officer View   
Mar 13, 2026Disclosure of Interest by a Director CEO, or Executive of a listed company and their Spouses and the Substantial Shareholders u/c 5.6.1.(d) of PSX Regulations View   
Mar 11, 2026Disclosure of Interest by a Director CEO, or Executive of a listed company and their Spouses and the Substantial Shareholders u/c 5.6.1.(d) of PSX Regulations View   
Mar 11, 2026Disclosure of Interest by a Director CEO, or Executive of a listed company and their Spouses and the Substantial Shareholders u/c 5.6.1.(d) of PSX Regulations View   

Financials

All numbers in thousands (000's) except EPS

Annual
Quarterly
2025202420232022
Sales13,153,52112,409,23912,396,9839,779,880
Profit after Taxation892,039833,464657,984635,884
EPS3.903.652.882.88
Q2 2026Q1 2026Q3 2025Q2 2025
Sales4,332,5663,370,2473,341,1083,534,432
Profit after Taxation404,334203,691220,375256,979
EPS1.770.890.961.12
Data powered by Capital Stake. To provide comparable data, information might have been standardized. The data presented may therefore differ from issuer's annual report and 'as reported' data should be obtained directly from the source issuer. See the Capital Stake Terms of Use.

Ratios

2025202420232022
Gross Profit Margin (%)15.3412.7812.1613.83
Net Profit Margin (%)6.786.725.316.50
EPS Growth (%)6.8526.74(20.88)
PEG3.140.29(0.54)

Payouts

Financial Reports